D
2seventy bio, Inc. TSVT
$4.99 -$0.01-0.20% NASDAQ
Recommendation
Prev Close
$4.99
Volume
347,591
Avg Vol (90D)
1,058,748
Market Cap
$265.62M
Dividend & Yield
--
52-Week Range
$2.29 - $5.30
P/E (TTM)
--
EPS (TTM)
-$0.104
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
2seventy bio (TSVT, $4.99) RSI Indicator left the overbought zone on May 09, 2025
5/10/2025 - Tickeron - Technical Analysis
2seventy bio (TSVT) Projected to Post Quarterly Earnings on Wednesday
5/9/2025 - MarketBeat
2seventy bio (TSVT, $5) RSI Indicator left the overbought zone on May 07, 2025
5/8/2025 - Tickeron - Stocks
2seventy bio Inc (TSVT) Q1 2025 Earnings: EPS of $0.01 Beats Estimate, Revenue Surges to $22. ...
5/7/2025 - GuruFocus
2seventy bio Reports First Quarter Financial Results and Provides Update on Proposed ...
5/7/2025 - GuruFocus
2seventy bio Reports First Quarter Financial Results and Provides Update on Proposed Acquisition by Bristol Myers Squibb
5/7/2025 - Business Wire
2seventy bio (TSVT, $4.99) RSI Indicator left the overbought zone on May 06, 2025
5/7/2025 - Tickeron - Stocks
Susquehanna Fundamental Investments LLC Makes New Investment in 2seventy bio, Inc. (NASDAQ:TSVT)
5/5/2025 - Ticker Report
2seventy bio (TSVT, $5) RSI Indicator left the overbought zone on May 02, 2025
5/3/2025 - Tickeron - Stocks
2seventy bio, Inc. (NASDAQ:TSVT) Shares Sold by Marshall Wace LLP
5/3/2025 - MarketBeat
2seventy bio (TSVT, $4.98) RSI Indicator left the overbought zone on May 01, 2025
5/2/2025 - Tickeron - Technical Analysis
2seventy bio, Inc. (NASDAQ:TSVT) Given Average Recommendation of "Hold" by Brokerages
5/1/2025 - MarketBeat
2seventy bio (NASDAQ:TSVT) Earns Sell (E+) Rating from Weiss Ratings
4/27/2025 - MarketBeat
Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?
4/17/2025 - Zacks Investment Research
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BHLB, TSVT, RDFN on Behalf of Shareholders
4/17/2025 - PR Newswire
2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT
4/16/2025 - Business Wire
BMY Down on Heart Drug Camzyos Failure in Late-Stage Study
4/15/2025 - Zacks Investment Research
Martingale Asset Management L P Sells 42,658 Shares of 2seventy bio, Inc. (NASDAQ:TSVT)
4/15/2025 - Ticker Report
Weiss Ratings Reiterates Sell (D-) Rating for 2seventy bio (NASDAQ:TSVT)
4/10/2025 - MarketBeat
2seventy bio (TSVT, $4.89) RSI Indicator left the overbought zone on April 08, 2025
4/9/2025 - Tickeron - Technical Analysis
2seventy bio (TSVT, $4.95) entered Downtrend as Momentum indicator drops below 0 level on Apr 07, 2025
4/8/2025 - Tickeron - Stocks
CHMP Issues Positive Opinion for Label Expansion of BMY's Opdivo
4/1/2025 - Zacks Investment Research
2seventy bio, Inc. (NASDAQ:TSVT) Sees Large Drop in Short Interest
4/1/2025 - Ticker Report
2seventy bio (TSVT, $4.94) entered Downtrend as Momentum indicator drops below 0 level on Mar 31, 2025
4/1/2025 - Tickeron - Stocks
2seventy bio, Inc. (NASDAQ:TSVT) Short Interest Update
3/31/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$48.37M
EBITDA (TTM)
-$52.72M
EBIT (TTM)
-$59.35M
Net Income (TTM)
-$4.09M
Balance Sheet
Total Assets (Q)
$480.01M
Total Debt (Q)
$239.76M
Total Liabilities (Q)
$266.04M
Book Value Per Share (Q)
$4.08
Cash Flow
Cash from Operations (TTM)
-$54.09M
Cash from Investing (TTM)
$98.56M
Cash from Financing (TTM)
$531.00K
Net Change in Cash (TTM)
$44.99M
Filings
Filing Date
Wednesday, May 7, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
0.62
7-Day Total Return
0.20%
30-Day Total Return
0.81%
60-Day Total Return
95.69%
90-Day Total Return
72.66%
Year to Date Total Return
68.58%
1-Year Total Return
13.93%
2-Year Total Return
-57.68%
3-Year Total Return
-60.11%
5-Year Total Return
--
52-week Low
Feb 07, 2025 - $2.29
52-week High
Oct 22, 2024 - $5.30
Valuation
Market Cap
$265.62M - Micro Cap
Enterprise Value
$332.02M
Price/Sales (TTM)
5.51
Price/Book (Q)
1.22
Dividends and Shares
Shares Outstanding
53.43M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.2seventybio.com
Phone Number
617 675 7270
Address
60 Binney Street
Cambridge, MA 02142
Country
United States
Year Founded
2021
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company’s products pipeline... more
NASDAQ 05/09/2025 4:00PM Eastern Quotes delayed